Furthermore, we explored the clinicopathologic characteristics of RPA1-dependent, ETAA1-mediated events in liver cancer patients by analyzing the correlations between ETAA1 and RPA1 expression levels and liver cancer stages and tumor grades. This evidence concerns the gene ETAA1 and liver cancer.